Filing Details
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:SLS
SELLAS Life Sciences Group, Inc. (SLS) Reports Material Event to SEC
Filing Details SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market…
Market Context
SELLAS Life Sciences Group, Inc.'s stock currently trades at $10.53 with a market capitalization of $211.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for SELLAS Life Sciences Group, Inc.'s stock.
All SEC filings for SELLAS Life Sciences Group, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SLS Stock Page
Frequently Asked Questions
Where can I read SLS's SEC filings?
Browse all filings on our SLS SEC filings page.
What types of SEC filings does SELLAS Life Sciences Group, Inc. file?
Public companies like SELLAS Life Sciences Group, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.